BHVN - Biohaven Pharmaceutical Holding Co Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BHVN is currently covered by 11 analysts with an average price target of $16.3. This is a potential upside of $4.55 (38.72%) from yesterday's end of day stock price of $11.75.

Biohaven Pharmaceutical Holding Co Ltd's activity chart (see below) currently has 161 price targets and 163 ratings on display. The stock rating distribution of BHVN is 73.33% BUY and 26.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.66% with an average time for these price targets to be met of 520.13 days.

Highest price target for BHVN is $30, Lowest price target is $10, average price target is $16.3.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 10-Sep-2026.

Currently out of the existing stock ratings of BHVN, 22 are a BUY (73.33%), 8 are a HOLD (26.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Dec-2025

$10

$-2.87 (-22.30%)

$10

1 months 12 days ago
(10-Sep-2026)

4/15 (26.67%)

$-2.79 (-21.81%)

23

Buy Since 03-Mar-2026

$19

$6.13 (47.63%)

$22

1 months 14 days ago
(08-Sep-2026)

0/16 (0%)

$4.28 (29.08%)

Buy Since 24-Jul-2024

$19

$6.13 (47.63%)

$21

2 months 10 days ago
(12-Aug-2026)

0/8 (0%)

$4.61 (32.04%)

Hold Since 29-Jun-2026

$11

$-1.87 (-14.53%)

$10

3 months 23 days ago
(29-Jun-2026)

1/5 (20%)

$-3.95 (-26.42%)

23

Buy Since 17-Sep-2025

$17

$4.13 (32.09%)

$17

6 months 10 days ago
(12-Apr-2026)

1/4 (25%)

$7.83 (85.39%)

222

Show more analysts

Please expand the browser size to see the chart

What is BHVN (Biohaven Pharmaceutical Holding Co Ltd) average time for price targets to be met?

On average it took 520 days for the stock forecasts to be reached, with an average price target met ratio of 27.66%.

Which analyst most recently updated their price target on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?

Douglas Tsao

Which analyst has the most public recommendations on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?

Douglas Tsao has 50 price targets and 39 ratings on BHVN

Which analyst is the currently most bullish on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?

Matthew Harrison with the highest potential upside of $1475.83

Which analyst is the currently most reserved on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?

Douglas Tsao with the lowest potential downside of -$2.87
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?